Valproic acid

Research use only, not for human use.

A HDAC inhibitor that selectively inhibits the catalytic activity of class I HDACs, and induces proteasomal degradation of HDAC2.

A HDAC inhibitor that selectively inhibits the catalytic activity of class I HDACs, and induces proteasomal degradation of HDAC2; induces differentiation of carcinoma cells, transformed hematopoietic progenitor cells and leukemic blasts from AML patients; reduces tumor growth and metastasis formation in animal model.Migraine Approved

VPA;2-Propylpentanoic Acid

Cell Cycle/DNA Damage

HDAC

GABA; Sodium Channel; HDACs

Neurological Disease

Migraine

99-66-1

144.21

C8H16O2

>98% (HPLC)

10 mM in H2O

CCCC(CCC)C(O)=O

Pentanoic acid, 2-propyl-

(-20℃)

With Ice Pack

≥ 2 years